We have located links that may give you full text access.
Prognostic significance of the "surprise" question in cancer patients.
Journal of Palliative Medicine 2010 July
BACKGROUND: Physicians consistently overestimate survival for patients with cancer. The "surprise" question--"Would I be surprised if this patient died in the next year?"--improves end-of-life care by identifying patients with a poor prognosis. It has not been previously studied in patients with cancer.
OBJECTIVE: To determine the efficacy of the surprise question in patients with cancer.
DESIGN: Prospective cohort study.
SETTING: Academic cancer center.
PATIENTS: 853 consecutive patients with breast, lung, or colon cancer.
MEASUREMENTS: Surprise question classification and patient status at 12 months, alive or dead, by surprise question response.
RESULTS: Oncologists classified 826 of 853 prospective patients with cancer (97%) with 131 (16%) classified into the "No" group and 695 (84%) into the "Yes" group. In multivariate analysis, a "No" response identified patients with cancer who had a seven times greater hazard of death in the next year compared to patients in the "Yes" group (HR 7.787, p < 0.001).
LIMITATIONS: Single center study.
CONCLUSION: The surprise question is a simple, feasible, and effective tool to identify patients with cancer who have a greatly increased risk of 1-year mortality.
OBJECTIVE: To determine the efficacy of the surprise question in patients with cancer.
DESIGN: Prospective cohort study.
SETTING: Academic cancer center.
PATIENTS: 853 consecutive patients with breast, lung, or colon cancer.
MEASUREMENTS: Surprise question classification and patient status at 12 months, alive or dead, by surprise question response.
RESULTS: Oncologists classified 826 of 853 prospective patients with cancer (97%) with 131 (16%) classified into the "No" group and 695 (84%) into the "Yes" group. In multivariate analysis, a "No" response identified patients with cancer who had a seven times greater hazard of death in the next year compared to patients in the "Yes" group (HR 7.787, p < 0.001).
LIMITATIONS: Single center study.
CONCLUSION: The surprise question is a simple, feasible, and effective tool to identify patients with cancer who have a greatly increased risk of 1-year mortality.
Full text links
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app